Assenagon Asset Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,833
Closed -$319K 1212
2025
Q4
$319K Hold
13,833
﹤0.01% 1089
2025
Q3
$372K Sell
13,833
-150,255
-92% -$3.58M ﹤0.01% 1093
2025
Q2
$2.75M Buy
164,088
+111,686
+213% +$1.97M ﹤0.01% 694
2025
Q1
$924K Buy
52,402
+239
+0.5% +$4.79K ﹤0.01% 917
2024
Q4
$1.27M Sell
52,163
-38,271
-42% -$1.09M ﹤0.01% 1057
2024
Q3
$3.36M Buy
90,434
+2,047
+2% +$76.3K 0.01% 814
2024
Q2
$4.21M Sell
88,387
-116,226
-57% -$5.09M 0.01% 684
2024
Q1
$7.83M Buy
+204,613
New +$6.65M 0.02% 490
2023
Q4
Sell
-434,886
Closed -$17.5M 1487
2023
Q3
$17.5M Sell
434,886
-10,994
-2% -$515K 0.05% 274
2023
Q2
$23.4M Buy
445,880
+234,493
+111% +$14.3M 0.08% 205
2023
Q1
$13.5M Buy
+211,387
New +$13.8M 0.05% 316
2022
Q4
Sell
-7,617
Closed -$537K 1446
2022
Q3
$537K Sell
7,617
-34,230
-82% -$2.93M ﹤0.01% 1091
2022
Q2
$2.97M Sell
41,847
-832
-2% -$53.6K 0.01% 698
2022
Q1
$3.41M Buy
42,679
+37,211
+681% +$2.77M 0.01% 647
2021
Q4
$499K Sell
5,468
-43,956
-89% -$4.72M ﹤0.01% 1199
2021
Q3
$6.35M Buy
+49,424
New +$6.92M 0.02% 366
2021
Q2
Sell
-68,278
Closed -$7.2M 1402
2021
Q1
$7.2M Buy
68,278
+44,273
+184% +$4.43M 0.03% 418
2020
Q4
$1.9M Sell
24,005
-220,125
-90% -$16.1M 0.01% 535
2020
Q3
$13.8M Buy
+244,130
New +$13.1M 0.08% 158
2020
Q1
Sell
-14,740
Closed -$518K 980
2019
Q4
$518K Buy
+14,740
New +$486K ﹤0.01% 656
2018
Q4
Sell
-51,002
Closed -$2.45M 1135
2018
Q3
$2.45M Buy
+51,002
New +$2.09M 0.02% 479

Other funds holding STAA

Assenagon Asset Management's STAA Position: Q1 2026 in Review

Assenagon Asset Management sold out of STAAR Surgical (STAA) in Q1 2026, closing a stake of 13,833 shares — an estimated $319K sold.

Assenagon Asset Management first reported a position in STAA in Q3 2018 and held it in 21 quarters. The position peaked at $23.4M in Q2 2023. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • Assenagon Asset Management reported no remaining STAAR Surgical position as of Q1 2026 after selling out during the quarter.
  • Assenagon Asset Management sold 13,833 STAAR Surgical shares in Q1 2026, an estimated $319K.
  • Assenagon Asset Management first reported a position in STAAR Surgical in Q3 2018 and held it in 21 quarters.
  • Assenagon Asset Management's STAAR Surgical position peaked at $23.4M in Q2 2023.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Assenagon Asset Management's 13F filing for Q1 2026, filed 20 Apr 2026.